Publications by authors named "Marina Gilli"

Claim this Profile
T
The Italian Mauris Phase IIIb Trial of Atezolizumab Plus Carboplatin and Etoposide for Patients With Newly Diagnosed Extensive-Stage Small Cell Lung Cancer: 3-Year End-of-Study Results.
Floriana Morgillo, Ester Del Signore, Emilio Bria, Filippo de Marinis, Fortunato Ciardiello, Marina Gilli

Clin Lung Cancer· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of Atezolizumab in Addition to Chemotherapy in ES-SCLC: A Retrospective Real-World Monocentric Study.
Raffaella Pagliaro, Fabiana Vitiello, Marina Gilli, Antonio d'Orologio, Luca Borgese

Cancers (Basel)· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world effectiveness and safety of first-line chemoimmunotherapy combinations in metastatic non-small cell lung cancer with programmed death ligand-1 < 50%: results from an Italian observational study.
Alessandro Inno, Antonello Veccia, Ettore D'Argento, Floriana Morgillo, Elio Gregory Pizzutilo, Marina Gilli

Cancer Immunol Immunother· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atezolizumab Plus Carboplatin and Etoposide in Patients with Untreated Extensive-Stage Small-Cell Lung Cancer: Interim Results of the MAURIS Phase IIIb Trial.
Emilio Bria, Floriana Morgillo, Marina Chiara Garassino, Fortunato Ciardiello, Andrea Ardizzoni, Marina Gilli

Oncologist· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Consolidative thoracic radiation therapy for extensive-stage small cell lung cancer in the era of first-line chemoimmunotherapy: preclinical data and a retrospective study in Southern Italy.
Vito Longo, Carminia Maria Della Corte, Alessandro Russo, Francesca Spinnato, Francesca Ambrosio, Marina Gilli

Front Immunol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complete response to pembrolizumab as a single agent in a patient with stage III NSCLC with high PD-L1 expression: a case report.
Paola Maria Medusa, Marina Gilli, Luca Notizia, Raffaella Pagliaro, Nicola Carro

Monaldi Arch Chest Dis· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Moving Immune Checkpoint Inhibitors to Early Non-Small Cell Lung Cancer: A Narrative Review.
Giuseppe Viscardi, Fabiana Vitiello, Alberto Servetto, Valerio Gristina, Elio Gregory Pizzutilo, Marina Gilli

Cancers (Basel)· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endoscopic central airway recanalization to enable first line pembrolizumab treatment in a PD-L1 strongly positive non-small cell lung cancer: a case report.
Alfonso Fiorelli, Fabio Perrotta, Mariano Mollica, Mario Santini, Fabiana Vitiello, Marina Gilli

J Cardiothorac Surg· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Listening understanding and acting (lung): focus on communicational issue in thoracic oncology.
Claudia Yvonne Finocchiaro, Alessandra Rota, Vito Barbieri, Anna Bettini, Roberto Bianco, Marina Gilli

Transl Cancer Res· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bullous pemphigoid and nivolumab: Dermatologic management to support and continue oncologic therapy.
Luigia Panariello, Davide Fattore, Maria Carmela Annunziata, Francovito Piantedosi, Marina Gilli

Eur J Cancer· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of FDG-PET scan in staging of pulmonary epithelioid hemangioendothelioma.
Cecilia Calabrese, Marina Gilli, Nicolina De Rosa, Vincenzo Di Crescenzo, Pio Zeppa

Open Med (Wars)· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis